Several signaling pathways have been identified that mediate the increased CD47 expression in specific cancers [17,18,19,20,21,22,23], but the possibility has not been considered that transcription regulators interacting with the promoter region of CD47 may simultaneously regulate expression of the adjacent IFT57. This evidence concerns the gene IFT57 and cancer.